‘Some encouraging signs in the market’: Electra shines with $183M fundraise for rare disease trial
Electra Therapeutics is incandescent, glowing on the heels of a $183 million series C financing intended to fuel the biotech’s just-launched pivotal trial for its rare disease candidate. Nextech and…